Document is current
Any future updates will be listed below
-
Authors
Bukun, Hulya Odabasi https://orcid.org/0009-0000-5432-4981
Uygunoglu, Ugur https://orcid.org/0000-0003-2866-4004
Senturk, Esra Firat https://orcid.org/0000-0002-0493-1705
Duru, Guzin https://orcid.org/0000-0002-4774-9284
Kızılkılıç, Osman https://orcid.org/0000-0002-6620-8934
Esatoglu, Sinem Nihal https://orcid.org/0000-0001-5414-7305
Melikoglu, Melike https://orcid.org/0000-0003-0253-8368
Seyahi, Emire https://orcid.org/0000-0003-4965-2918
-
Funding
Funding for this research was provided by:
Istanbul University Cerrahpaşa
- License Information
-
More Information
Article History
Received: 6 November 2025
Accepted: 22 January 2026
First Online: 7 February 2026
Declarations
:
: Emire Seyahi has received honoraria, consulting or speaker fees from Abbvie, UCB Pharma, Novartis, and Pfizer. Sinem Nihal Esatoglu has received honorariums for presentations from UCB Pharma, Celltrion, Pfizer and Merck Sharp Dohme. No other disclosures were reported.
